Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.2 Research Methodology
1.3 Research Assumptions
1.3.1 Estimates and Forecast Timeline
1.4 Research Methodology
1.5 Information Procurement
1.5.1 Purchased Database
1.5.2 Internal database
1.5.3 Secondary Sources
1.5.4 Primary Research
1.5.5 Details of Primary Research
1.6 Information or Data Analysis
1.6.1 Data Analysis Models
1.7 Market Formulation & Validation
1.8 Model Details
1.8.1 Commodity Flow Analysis
1.8.1.1 Approach 1: Commodity Flow Approach
1.8.1.2 Approach 2: Country wise market estimation using bottom up approach
1.9 Global Market: CAGR Calculation
1.10 List of Secondary Sources
1.11 List of Primary Sources
1.12 Objectives
1.12.1 Objective 1:
1.12.2 Objective 2:
1.13 List of Tables

Chapter 2 Executive Summary
2.1 Market Summary

Chapter 3 Molecular Diagnostics Market Variables, Trends & Scope
3.1 Molecular Diagnostics Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Regulatory and Reimbursement Framework
3.4 Market Dynamics
3.4.1 Market driver analysis
3.4.1.1 Increase in geriatric population
3.4.1.2 Introduction of technologically advanced products
3.4.1.3 Increase in demand for point-of-care facilities
3.4.1.4 Growing prevalence of target diseases
3.4.1.5 Increasing external funding for R&D
3.4.2 Market restraint analysis
3.4.2.1 Presence of ambiguous regulatory framework
3.4.2.2 High prices of molecular diagnostics tests
3.5 Molecular Diagnostics Market Analysis Tools
3.5.1 Porter's Five Forces Analysis
3.5.2 SWOT Analysis, By factor (Political & Legal, Economic and Technological)
3.5.3 Major deals & strategic alliances analysis
3.5.3.1 New product launch
3.5.3.2 Mergers and acquisitions
3.5.3.3 Expansion
3.5.3.4 Partnerships
3.5.3.5 Marketing & promotions
3.5.3.6 Market entry strategies

Chapter 4 Molecular Diagnostics Market - Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.1.1 Company/Competition Categorization (Key innovators, Market leaders, Expansion)
4.1.2 Innovators
4.2 Vendor Landscape
4.2.1 List of key distributors
4.2.2 Key company market share analysis, 2019
4.3 Public Companies
4.3.1 Company market position analysis
4.3.2 Competitive Dashboard Analysis
4.4 Private Companies
4.4.1 List of key emerging companies /technology disruptors/innovators
4.4.2 Regional network map

Chapter 5 Products Business Analysis
5.1 Molecular diagnostics market: Products Movement Analysis
5.2 Instruments
5.2.1 Instruments market estimates and forecast, 2016 - 2027
5.3 Reagents
5.3.1 Reagents market estimates and forecast, 2016 - 2027
5.4 Others
5.4.1 Others market estimates and forecast, 2016 - 2027

Chapter 6 Test Location Business Analysis
6.1 Molecular diagnostics market: Test Location Movement Analysis
6.2 Point of Care (PoC)
6.2.1 PoC market estimates and forecast, 2016 - 2027
6.3 Self-testing or OTC
6.3.1 Self-testing or OTC market estimates and forecast, 2016 - 2027
6.4 Central Laboratories
6.4.1 Central Laboratories market estimates and forecast, 2016 - 2027

Chapter 7 Technology Business Analysis
7.1 Molecular diagnostics market: Technology Movement Analysis
7.2 Polymerase Chain Reaction
7.2.1 Polymerase Chain Reaction market estimates and forecast, 2016 - 2027
7.2.2 PCR market, by Type
7.2.2.1 Multiplex PCR
7.2.2.1.1 Multiplex PCR market estimates and forecast, 2016 - 2027
7.2.2.2 Other PCR
7.2.2.2.1 Other PCR market estimates and forecast, 2016 - 2027
7.2.3 PCR market, by Product
7.2.3.1 Instruments
7.2.3.1.1 Instruments market for PCR estimates and forecast, 2016 - 2027
7.2.3.2 Reagents
7.2.3.2.1 Reagents market for PCR estimates and forecast, 2016 - 2027
7.2.3.3 Others
7.2.3.3.1 Others market for PCR estimates and forecast, 2016 - 2027
7.3 In Situ Hybridization (ISH)
7.3.1 In Situ Hybridization market estimates and forecast, 2016 - 2027
7.3.2 Instruments
7.3.2.1 Instruments market for ISH estimates and forecast, 2016 - 2027
7.3.3 Reagents
7.3.3.1 Reagents market for ISH estimates and forecast, 2016 - 2027
7.3.4 Others
7.3.4.1 Others market for ISH estimates and forecast, 2016 - 2027
7.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
7.4.1 INAAT market estimates and forecast, 2016 - 2027
7.4.2 Instruments
7.4.2.1 Instruments market for INAAT estimates and forecast, 2016 - 2027
7.4.3 Reagents
7.4.3.1 Reagents market for INAAT estimates and forecast, 2016 - 2027
7.4.4 Others
7.4.4.1 Others market for INAAT estimates and forecast, 2016 - 2027
7.5 Chips and Microarrays
7.5.1 Chips and Microarrays market estimates and forecast, 2016 - 2027
7.5.2 Instruments
7.5.2.1 Instruments market for Chips and microarrays estimates and forecast, 2016 - 2027
7.5.3 Reagents
7.5.3.1 Reagents market for Chips and microarrays estimates and forecast, 2016 - 2027
7.5.4 Others
7.5.4.1 Others market for Chips and microarrays estimates and forecast, 2016 - 2027
7.6 Mass Spectrometry
7.6.1 Mass Spectrometry market estimates and forecast, 2016 - 2027
7.6.2 Instruments
7.6.2.1 Instruments market for Mass spectrometry estimates and forecast, 2016 - 2027
7.6.3 Reagents
7.6.3.1 Reagents market for mass spectrometry estimates and forecast, 2016 - 2027
7.6.4 Others
7.6.4.1 Others market for mass spectrometry estimates and forecast, 2016 - 2027
7.7 Sequencing
7.7.1 Sequencing market estimates and forecast, 2016 - 2027
7.7.2 Instruments
7.7.2.1 Instruments market for Sequencing estimates and forecast, 2016 - 2027
7.7.3 Reagents
7.7.3.1 Reagents market for sequencing estimates and forecast, 2016 - 2027
7.7.4 Others
7.7.4.1 Others market for sequencing estimates and forecast, 2016 - 2027
7.8 Transcription Mediated Amplification (TMA)
7.8.1 TMA market estimates and forecast, 2016 - 2027
7.8.2 Instruments
7.8.2.1 Instruments market for TMA estimates and forecast, 2016 - 2027
7.8.3 Reagents
7.8.3.1 Reagents market for TMA estimates and forecast, 2016 - 2027
7.8.4 Others
7.8.4.1 Others market for TMA estimates and forecast, 2016 - 2027
7.9 Others
7.9.1 Others market estimates and forecast, 2016 - 2027
7.9.2 Instruments
7.9.2.1 Instruments market for Others estimates and forecast, 2016 - 2027
7.9.3 Reagents
7.9.3.1 Reagents market for others estimates and forecast, 2016 - 2027
7.9.4 Others
7.9.4.1 Others market for Others estimates and forecast, 2016 - 2027

Chapter 8 Application Business Analysis
8.1 Molecular diagnostics market: Application Movement Analysis
8.2 Oncology
8.2.1 Oncology market estimates and forecast, 2016 - 2027
8.2.2 Breast cancer
8.2.2.1 Breast cancer market estimates and forecast, 2016 - 2027
8.2.3 Prostate cancer
8.2.3.1 Prostate cancer market estimates and forecast, 2016 - 2027
8.2.4 Colorectal cancer
8.2.4.1 Colorectal cancer market estimates and forecast, 2016 - 2027
8.2.5 Cervical cancer
8.2.5.1 Cervical cancer market estimates and forecast, 2016 - 2027
8.2.6 Kidney cancer
8.2.6.1 Kidney cancer market estimates and forecast, 2016 - 2027
8.2.7 Liver cancer
8.2.7.1 Liver cancer market estimates and forecast, 2016 - 2027
8.2.8 Blood cancer
8.2.8.1 Blood cancer market estimates and forecast, 2016 - 2027
8.2.9 Lung cancer
8.2.9.1 Lung cancer market estimates and forecast, 2016 - 2027
8.2.10 Other cancers
8.2.10.1 Other cancer market estimates and forecast, 2016 - 2027
8.3 Pharmacogenomics
8.3.1 Pharmacogenomics Market estimates and forecast, 2016 - 2027
8.4 Infectious Diseases
8.4.1 Infectious Diseases market estimates and forecast, 2016 - 2027
8.4.2 Methicillin-resistant Staphylococcus Aureus (MRSA)
8.4.2.1 MRSA market estimates and forecast, 2016 - 2027
8.4.3 Clostridium difficile
8.4.3.1 Clostridium difficile market estimates and forecast, 2016 - 2027
8.4.4 Vancomycin-Resistant Enterococci (VRE)
8.4.4.1 VRE market estimates and forecast, 2016 - 2027
8.4.5 Carbapenem-resistant bacteria
8.4.5.1 Carbapenem-resistant bacteria market estimates and forecast, 2016 - 2027
8.4.6 Flu
8.4.6.1 Flu market estimates and forecast, 2016 - 2027
8.4.7 Respiratory Syncytial Virus (RSV)
8.4.7.1 RSV market estimates and forecast, 2016 - 2027
8.4.8 Candida
8.4.8.1 Candida market estimates and forecast, 2016 - 2027
8.4.9 Tuberculosis (TB) and drug-resistant TBA
8.4.9.1 TB and drug-resistant TB market estimates and forecast, 2016 - 2027
8.4.10 Meningitis
8.4.10.1 Meningitis market estimates and forecast, 2016 - 2027
8.4.11 Gastrointestinal panel testing
8.4.11.1 Gastrointestinal panel testing market estimates and forecast, 2016 - 2027
8.4.12 Chlamydia
8.4.12.1 Chlamydia market estimates and forecast, 2016 - 2027
8.4.13 Gonorrhea
8.4.13.1 Gonorrhea market estimates and forecast, 2016 - 2027
8.4.14 HIV
8.4.14.1 HIV market estimates and forecast, 2016 - 2027
8.4.15 Hepatitis C
8.4.15.1 Hepatitis C market estimates and forecast, 2016 - 2027
8.4.16 Hepatitis B
8.4.16.1 Hepatitis B market estimates and forecast, 2016 - 2027
8.4.17 Other infectious disease market
8.4.17.1 Other infectious disease market estimates and forecast, 2016 - 2027
8.5 Genetic Testing
8.5.1 Genetic Testing Market estimates and forecast, 2016 - 2027
8.5.2 Newborn screening
8.5.2.1 Newborn screening market estimates and forecast, 2016 - 2027
8.5.3 Predictive and Presymptomatic testing
8.5.3.1 Predictive and Presymptomatic testing market estimates and forecast, 2016 - 2027
8.5.4 Other genetic testing
8.5.4.1 Other genetic testing market estimates and forecast, 2016 - 2027
8.6 Neurological Diseases
8.6.1 Neurological Diseases Market estimates and forecast, 2016 - 2027
8.7 Cardiovascular Diseases
8.7.1 Cardiovascular Diseases Market estimates and forecast, 2016 - 2027
8.8 Microbiology
8.8.1 Microbiology Market estimates and forecast, 2016 - 2027
8.9 Others
8.9.1 Others Market estimates and forecast, 2016 - 2027

Chapter 9 Regional Business Analysis
9.1 Molecular diagnostics market: Regional Movement Analysis
9.2 North America
9.2.1 North America, SWOT Analysis
9.2.2 U.S.
9.2.3 Canada
9.3 Europe
9.3.1 Europe, SWOT Analysis
9.3.2 U.K.
9.3.3 Germany
9.3.4 France
9.3.5 Italy
9.3.6 Spain
9.3.7 Belgium
9.3.8 Switzerland
9.3.9 Netherlands
9.3.10 Poland
9.3.11 Austria
9.3.12 Greece
9.3.13 Sweden
9.3.14 Turkey
9.3.15 Finland
9.4 Asia Pacific
9.4.1 Asia Pacific, SWOT Analysis
9.4.2 India
9.4.3 China
9.4.4 Japan
9.4.5 Sri Lanka
9.4.6 Malaysia
9.4.7 Australia
9.4.8 New Zealand
9.4.9 Thailand
9.4.10 Vietnam
9.4.11 Singapore
9.5 Latin America
9.5.1 Latin America, SWOT Analysis
9.5.2 Mexico
9.5.3 Brazil
9.5.4 Chile
9.5.5 Peru
9.5.6 Colombia
9.5.7 Argentina
9.6 MEA
9.6.1 Middle East & Africa, SWOT Analysis
9.6.2 South Africa
9.6.3 Saudi Arabia
9.6.4 Jordan
9.6.5 UAE
9.6.6 Qatar
9.6.7 Nigeria
9.6.8 Egypt

Chapter 10 Company Profiles
10.1 Market Participation Categorization
10.2 Company Profiles
10.2.1 Abbott
10.2.1.1 Company overview
10.2.1.2 Alere, Inc.
10.2.1.3 Financial performance
10.2.1.4 Product benchmarking
10.2.1.5 Strategic initiatives
10.2.2 Becton, Dickinson and Company
10.2.2.1 Company overview
10.2.2.2 Financial performance
10.2.2.3 Product benchmarking
10.2.2.4 Strategic initiatives
10.2.3 bioMérieux SA
10.2.3.1 Company overview
10.2.3.2 Financial performance
10.2.3.3 Product benchmarking
10.2.3.4 Strategic initiatives
10.2.4 Bio-Rad Laboratories, Inc.
10.2.4.1 Company overview
10.2.4.2 Financial performance
10.2.4.3 Product benchmarking
10.2.4.4 Strategic initiatives
10.2.5 Agilent Technologies, Inc.
10.2.5.1 Company overview
10.2.5.2 Financial performance
10.2.5.3 Product benchmarking
10.2.5.4 Strategic initiatives
10.2.6 Danaher Corporation
10.2.6.1 Company overview
10.2.6.2 Cepheid
10.2.6.3 Beckman Coulter
10.2.6.4 Leica Biosystems
10.2.6.5 Financial performance
10.2.6.6 Product benchmarking
10.2.6.7 Strategic initiatives
10.2.6.8 Strategic initiatives of Cepheid
10.2.6.9 Strategic initiatives of Beckman Coulter, Inc.
10.2.6.10 Strategic initiatives of Leica Biosystems
10.2.7 Hologic, Inc. (Gen Probe)
10.2.7.1 Company overview
10.2.7.2 Financial performance
10.2.7.3 Product benchmarking
10.2.7.4 Strategic initiatives
10.2.8 Illumina, Inc.
10.2.8.1 Company overview
10.2.8.2 Financial performance
10.2.8.3 Product benchmarking
10.2.8.4 Strategic initiatives
10.2.9 Johnson & Johnson Services, Inc.
10.2.9.1 Company overview
10.2.9.2 Financial performance
10.2.9.3 Product benchmarking
10.2.9.4 Strategic initiatives
10.2.10 Novartis (Grifols)
10.2.10.1 Company overview
10.2.10.2 Financial performance
10.2.10.3 Product benchmarking
10.2.10.4 Strategic initiatives
10.2.11 Qiagen
10.2.11.1 Company overview
10.2.11.2 Financial performance
10.2.11.3 Product benchmarking
10.2.11.4 Strategic initiatives
10.2.12 F. Hoffmann-La Roche Ltd
10.2.12.1 Company overview
10.2.12.2 Financial performance
10.2.12.3 Product benchmarking
10.2.12.4 Strategic initiatives
10.2.13 Siemens Healthcare Private Limited
10.2.13.1 Company overview
10.2.13.2 Financial performance
10.2.13.3 Product benchmarking
10.2.13.4 Strategic initiatives
10.2.14 Sysmex Corporation
10.2.14.1 Company overview
10.2.14.2 Financial performance
10.2.14.3 Product benchmarking
10.2.14.4 Strategic initiatives

List of Tables
TABLE 1 Country share estimation
TABLE 2 North America molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 3 North America molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
TABLE 4 North America molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 5 North America PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
TABLE 6 North America PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 7 North America ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 8 North America INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 9 North America chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 10 North America mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 11 North America sequencing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 12 North America TMA market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 13 North America others technology market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 14 North America molecular diagnostics market estimates and forecasts, by application, 2016 - 2027 (USD Million)
TABLE 15 North America molecular diagnostics market estimates and forecasts, by oncology, 2016 - 2027 (USD Million)
TABLE 16 North America molecular diagnostics market estimates and forecasts, by infectious diseases, 2016 - 2027 (USD Million)
TABLE 17 North America molecular diagnostics market estimates and forecasts, by genetic testing, 2016 - 2027 (USD Million)
TABLE 18 U.S. molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 19 U.S. molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
TABLE 20 U.S. molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 21 U.S. PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
TABLE 22 U.S. PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 23 U.S. ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 24 U.S. INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 25 U.S. chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 26 U.S. mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 27 U.S. sequencing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 28 U.S. TMA market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 29 U.S. others technology market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 30 U.S. molecular diagnostics market estimates and forecasts, by application, 2016 - 2027 (USD Million)
TABLE 31 U.S. molecular diagnostics market estimates and forecasts, by oncology, 2016 - 2027 (USD Million)
TABLE 32 U.S. molecular diagnostics market estimates and forecasts, by infectious diseases, 2016 - 2027 (USD Million)
TABLE 33 U.S. molecular diagnostics market estimates and forecasts, by genetic testing, 2016 - 2027 (USD Million)
TABLE 34 Canada molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 35 Canada molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
TABLE 36 Canada molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 37 Canada PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
TABLE 38 Canada PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 39 Canada ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 40 Canada INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 41 Canada chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 42 Canada mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 43 Canada sequencing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 44 Canada TMA market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 45 Canada others technology market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 46 Canada molecular diagnostics market estimates and forecasts, by application, 2016 - 2027 (USD Million)
TABLE 47 Canada molecular diagnostics market estimates and forecasts, by oncology, 2016 - 2027 (USD Million)
TABLE 48 Canada molecular diagnostics market estimates and forecasts, by infectious diseases, 2016 - 2027 (USD Million)
TABLE 49 Canada molecular diagnostics market estimates and forecasts, by genetic testing, 2016 - 2027 (USD Million)
TABLE 50 Europe molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 51 Europe molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
TABLE 52 Europe molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 53 Europe PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
TABLE 54 Europe PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 55 Europe ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 56 Europe INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 57 Europe chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 58 Europe mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 59 Europe sequencing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 60 Europe TMA market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 61 Europe others technology market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 62 Europe molecular diagnostics market estimates and forecasts, by application, 2016 - 2027 (USD Million)
TABLE 63 Europe molecular diagnostics market estimates and forecasts, by oncology, 2016 - 2027 (USD Million)
TABLE 64 Europe molecular diagnostics market estimates and forecasts, by infectious diseases, 2016 - 2027 (USD Million)
TABLE 65 Europe molecular diagnostics market estimates and forecasts, by genetic testing, 2016 - 2027 (USD Million)
TABLE 66 U.K. molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 67 U.K. molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
TABLE 68 U.K. molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 69 U.K. PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
TABLE 70 U.K. PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 71 U.K. ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 72 U.K. INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 73 U.K. chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 74 U.K. mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 75 U.K. sequencing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 76 U.K. TMA market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 77 U.K. others technology market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 78 U.K. molecular diagnostics market estimates and forecasts, by application, 2016 - 2027 (USD Million)
TABLE 79 U.K. molecular diagnostics market estimates and forecasts, by oncology, 2016 - 2027 (USD Million)
TABLE 80 U.K. molecular diagnostics market estimates and forecasts, by infectious diseases, 2016 - 2027 (USD Million)
TABLE 81 U.K. molecular diagnostics market estimates and forecasts, by genetic testing, 2016 - 2027 (USD Million)
TABLE 82 Germany molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 83 Germany molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
TABLE 84 Germany molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 85 Germany PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
TABLE 86 Germany PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 87 Germany ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 88 Germany INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 89 Germany chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 90 Germany mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 91 Germany sequencing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 92 Germany TMA market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 93 Germany others technology market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 94 Germany molecular diagnostics market estimates and forecasts, by application, 2016 - 2027 (USD Million)
TABLE 95 Germany molecular diagnostics market estimates and forecasts, by oncology, 2016 - 2027 (USD Million)
TABLE 96 Germany molecular diagnostics market estimates and forecasts, by infectious diseases, 2016 - 2027 (USD Million)
TABLE 97 Germany molecular diagnostics market estimates and forecasts, by genetic testing, 2016 - 2027 (USD Million)
TABLE 98 France molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 99 France molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
TABLE 100 France molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 101 France PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
TABLE 102 France PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 103 France ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 104 France INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 105 France chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 106 France mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 107 France sequencing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 108 France TMA market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 109 France others technology market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 110 France molecular diagnostics market estimates and forecasts, by application, 2016 - 2027 (USD Million)
TABLE 111 France molecular diagnostics market estimates and forecasts, by oncology, 2016 - 2027 (USD Million)
TABLE 112 France molecular diagnostics market estimates and forecasts, by infectious diseases, 2016 - 2027 (USD Million)
TABLE 113 France molecular diagnostics market estimates and forecasts, by genetic testing, 2016 - 2027 (USD Million)
TABLE 114 Spain molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 115 Spain molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
TABLE 116 Spain molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 117 Spain PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
TABLE 118 Spain PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 119 Spain ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 120 Spain INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 121 Spain chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 122 Spain mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 123 Spain sequencing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 124 Spain TMA market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 125 Spain others technology market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 126 Spain molecular diagnostics market estimates and forecasts, by application, 2016 - 2027 (USD Million)
TABLE 127 Spain molecular diagnostics market estimates and forecasts, by oncology, 2016 - 2027 (USD Million)
TABLE 128 Spain molecular diagnostics market estimates and forecasts, by infectious diseases, 2016 - 2027 (USD Million)
TABLE 129 Spain molecular diagnostics market estimates and forecasts, by genetic testing, 2016 - 2027 (USD Million)
TABLE 130 Italy molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 131 Italy molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
TABLE 132 Italy molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 133 Italy PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
TABLE 134 Italy PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 135 Italy ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 136 Italy INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 137 Italy chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 138 Italy mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 139 Italy sequencing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 140 Italy TMA market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 141 Italy others technology market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 142 Italy molecular diagnostics market estimates and forecasts, by application, 2016 - 2027 (USD Million)
TABLE 143 Italy molecular diagnostics market estimates and forecasts, by oncology, 2016 - 2027 (USD Million)
TABLE 144 Italy molecular diagnostics market estimates and forecasts, by infectious diseases, 2016 - 2027 (USD Million)
TABLE 145 Italy molecular diagnostics market estimates and forecasts, by genetic testing, 2016 - 2027 (USD Million)
TABLE 146 Belgium molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 147 Belgium molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
TABLE 148 Belgium molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 149 Belgium PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
TABLE 150 Belgium PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 151 Belgium ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 152 Belgium INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 153 Belgium chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 154 Belgium mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 155 Belgium sequencing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 156 Belgium TMA market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 157 Belgium others technology market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 158 Belgium molecular diagnostics market estimates and forecasts, by application, 2016 - 2027 (USD Million)
TABLE 159 Belgium molecular diagnostics market estimates and forecasts, by oncology, 2016 - 2027 (USD Million)
TABLE 160 Belgium molecular diagnostics market estimates and forecasts, by infectious diseases, 2016 - 2027 (USD Million)
TABLE 161 Belgium molecular diagnostics market estimates and forecasts, by genetic testing, 2016 - 2027 (USD Million)
TABLE 162 Switzerland molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 163 Switzerland molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
TABLE 164 Switzerland molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 165 Switzerland PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
TABLE 166 Switzerland PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 167 Switzerland ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 168 Switzerland INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 169 Switzerland chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 170 Switzerland mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 171 Switzerland sequencing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 172 Switzerland TMA market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 173 Switzerland others technology market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 174 Switzerland molecular diagnostics market estimates and forecasts, by application, 2016 - 2027 (USD Million)
TABLE 175 Switzerland molecular diagnostics market estimates and forecasts, by oncology, 2016 - 2027 (USD Million)
TABLE 176 Switzerland molecular diagnostics market estimates and forecasts, by infectious diseases, 2016 - 2027 (USD Million)
TABLE 177 Switzerland molecular diagnostics market estimates and forecasts, by genetic testing, 2016 - 2027 (USD Million)
TABLE 178 Netherlands molecular diagnostics market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 179 Netherlands molecular diagnostics market estimates and forecasts, by test location, 2016 - 2027 (USD Million)
TABLE 180 Netherlands molecular diagnostics market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 181 Netherlands PCR market estimates and forecasts, by type, 2016 - 2027 (USD Million)
TABLE 182 Netherlands PCR market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 183 Netherlands ISH market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 184 Netherlands INAAT market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 185 Netherlands chips and microarrays market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 186 Netherlands mass spectrometry market estimates and forecasts, by product, 2016 - 2027 (USD Million)

Please contact our Customer Support Center to get the complete Table of Contents